BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10697563)

  • 1. Allogeneic class I major histocompatibility complex gene transfer in murine neuroblastoma in vivo.
    Ishida H; Kaneda Y; Yamane S; Sawada T; Plautz GE; Matsumura T
    Anticancer Res; 1999; 19(6B):5367-73. PubMed ID: 10697563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
    Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
    Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine neuroblastoma vaccines produced by retroviral transfer of MHC class II genes.
    Hock RA; Reynolds BD; Tucker-McClung CL; Heuer JG
    Cancer Gene Ther; 1996; 3(5):314-20. PubMed ID: 8894250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
    Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination therapy of experimental murine hepatoma with mIL-12 gene and MHC I gene mediated by liposome].
    Wang KM; Xia AD; Chen SS
    Ai Zheng; 2002 Oct; 21(10):1041-6. PubMed ID: 12508639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of antitumor response by in vivo allogeneic major histocompatibility complex gene transfer using electroporation.
    Shimizu H; Nukui Y; Mitsuhashi N; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Miyazaki M
    J Surg Res; 2009 Jun; 154(1):60-7. PubMed ID: 19101693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
    Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures.
    Cignetti A; Guarini A; Gillio Tos A; Reato G; Foa R
    Cancer Gene Ther; 2000 Feb; 7(2):167-76. PubMed ID: 10770624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipofection indirectly increases expression of endogenous major histocompatibility complex class I molecules on tumor cells.
    Fox BA; Drury M; Hu HM; Cao Z; Huntzicker EG; Qie W; Urba WJ
    Cancer Gene Ther; 1998; 5(5):307-12. PubMed ID: 9824050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic MHC gene transfer enhances an effective antitumor immunity in the early period of autologous hematopoietic stem cell transplantation.
    Kobayashi A; Hara H; Ohashi M; Nishimoto T; Yoshida K; Ohkohchi N; Yoshida T; Aoki K
    Clin Cancer Res; 2007 Dec; 13(24):7469-79. PubMed ID: 18094431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
    Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
    J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
    Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
    Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
    J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant chain+ N2a neuroblastoma cells stably expressing the class II MHC transactivator CIITA fail to stimulate anti-tumor immunity.
    Rickard S; Ono SJ
    Exp Mol Pathol; 2008 Dec; 85(3):147-54. PubMed ID: 18952077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation.
    Hara H; Kobayashi A; Narumi K; Kondoh A; Yoshida K; Nishimoto T; Ohashi M; Higashihara E; Ohnami S; Yoshida T; Aoki K
    Cancer Immunol Immunother; 2009 Jul; 58(7):1007-21. PubMed ID: 18998126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
    Kijima M; Saio M; Oyang GF; Suwa T; Miyauchi R; Kojima Y; Imai H; Nakagawa J; Nonaka K; Umemura N; Nishimura T; Takami T
    Int J Oncol; 2005 Mar; 26(3):679-84. PubMed ID: 15703823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH; Carew JF; Kooby DA; Shields J; Entwisle C; Patel S; Shah JP; Fong Y
    Cancer Gene Ther; 2000 Sep; 7(9):1279-85. PubMed ID: 11023201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase.
    Hasegawa H; Shimada M; Yonemitsu Y; Utsunomiya T; Gion T; Kaneda Y; Sugimachi K
    Cancer Gene Ther; 2001 Apr; 8(4):252-8. PubMed ID: 11393277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T; Martuza RL; Dallman MJ; Rabkin SD
    Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.